Skip to main content

Brown Vance R's Form 4 filing

Boston Scientific Corp (BSX) · filed May 23, 2024

Accession no.
0001225208-24-006324
Filed
May 23, 2024
Trade date
May 21-22, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $2.50M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Brown Vance RCIK 0001868243Officer (SVP, GC and Corp. Secretary)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 21, 2024Common StockMOption exerciseAcquired+18,037$24.55+$442,808.3550,363Direct
May 21, 2024Common StockSSaleDisposed−18,037$75.60F2−$1,363,597.232,326Direct
May 22, 2024Common StockMOption exerciseAcquired+15,006$27.09+$406,512.5447,332Direct
May 22, 2024Common StockSSaleDisposed−15,006$76.01F3−$1,140,606.0632,326Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 21, 2024Common StockMOption exerciseDisposed−18,037$0.00$00Direct
May 22, 2024Common StockMOption exerciseDisposed−15,006$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $75.505 to $75.74, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F3

Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $75.7650 to $76.22, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)